Abstract
BackgroundPulmonary function tests play a key role in assessment of systemic sclerosis (SSc) pulmonary manifestations. Reduction of diffusing lung capacity for carbon monoxide (DLCO) is evidence both pulmonary arterial hypertension(PAH)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
